nasdaq

Cypherpunk Accelerates Zcash Accumulation; Increases Treasury Holdings to 290,062.67 ZEC

CAMBRIDGE, Mass., Dec. 30, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), the privacy-focused technology company, today announced a…

5 days ago

Visionary Holdings (Nasdaq: GV) Appoints CEO of Health Technology Business, Establishes New Sales Entity in Nanjing to Accelerate Commercial Execution in China Market

December 30, 2025 09:30 ET  | Source: Visionary Holdings Inc. HONG KONG, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Visionary Holdings…

5 days ago

Akari Therapeutics Issues 2025 End of Year Letter to Shareholders

December 30, 2025 09:15 ET  | Source: Akari Therapeutics Plc TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) --…

5 days ago

IMUNON 2025, A TRANSFORMATIVE YEAR OF SIGNIFICANT CLINICAL ADVANCES, LOOKING AHEAD TO 2026

Enrollment in the Pivotal Phase 3 OVATION 3 Study Advances Company Toward Future BLA Filing New Data from MRD Study Reinforces…

6 days ago

WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026

Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or…

6 days ago

Solidion Technology Awarded A Second Grant From The U.S. Department of Energy For Nuclear Reactors

Grant Proceeds Will Accelerate Research Into Anti-Corrosive Additives in Molten-Salts-Based Heat Transfer Fluids For Nuclear Reactors.DALLAS, Dec. 29, 2025 /PRNewswire/…

7 days ago

Cycurion, Inc. (NASDAQ: CYCU) Announces Corrected Dividend Distribution Ratio of 0.0080 in Connection with its Previously Announced $500,000 Common Share Dividend

MCLEAN, Va., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”) refers to the press…

1 week ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert…

1 week ago

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

December 24, 2025 16:00 ET  | Source: XTL Biopharmaceuticals Ltd. RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL…

2 weeks ago

Radware Reports Results of 2025 Annual General Meeting

December 23, 2025 06:01 ET  | Source: Radware Ltd. TEL AVIV, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ:…

2 weeks ago